Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse

Folate receptor-positive circulating tumor cell count, lymphocyte count and derived neutrophil-to- lymphocyte ratio for diagnosing lung cancer relapse

The folate receptor-positive circulating tumor cell (FR+-CTC) count can be used to improve the diagnosis rate of lung cancer. The lymphocyte count (LC) and derived neutrophil-to-lymphocyte ratio (dNLR) are involved in inflammatory processes. Whether the FR+-CTC count combined with the dNLR or LC is...

Full description

Bibliographic Details
Main Authors: Huanrong Wang, Lei Liu, Jiaqin Yan, Wang Ma, Yabing Du, Tengfei Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
folate receptor-positive circulating tumor cell
lymphopenia
derived neutrophil-to-lymphocyte ratio
lung cancer
relapse
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1097816/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.1097816/full

Similar Items